APLS
Price
$25.00
Change
+$1.85 (+7.99%)
Updated
Oct 15, 11:16 AM (EDT)
Capitalization
2.92B
25 days until earnings call
Intraday Buy/Sell Signals
DAWN
Price
$7.38
Change
+$0.33 (+4.68%)
Updated
Oct 15, 11:14 AM (EDT)
Capitalization
722.66M
25 days until earnings call
Intraday Buy/Sell Signals
Interact to see
Advertisement

APLS vs DAWN

Header iconAPLS vs DAWN Comparison
Open Charts APLS vs DAWNBanner chart's image
Apellis Pharmaceuticals
Price$25.00
Change+$1.85 (+7.99%)
Volume$100
Capitalization2.92B
Day One Biopharmaceuticals
Price$7.38
Change+$0.33 (+4.68%)
Volume$600
Capitalization722.66M
APLS vs DAWN Comparison Chart in %
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APLS vs. DAWN commentary
Oct 17, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APLS is a Hold and DAWN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 17, 2025
Stock price -- (APLS: $23.15 vs. DAWN: $7.05)
Brand notoriety: APLS and DAWN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APLS: 67% vs. DAWN: 64%
Market capitalization -- APLS: $2.92B vs. DAWN: $722.66M
APLS [@Biotechnology] is valued at $2.92B. DAWN’s [@Biotechnology] market capitalization is $722.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $105.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.02B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APLS’s FA Score shows that 0 FA rating(s) are green whileDAWN’s FA Score has 0 green FA rating(s).

  • APLS’s FA Score: 0 green, 5 red.
  • DAWN’s FA Score: 0 green, 5 red.
According to our system of comparison, both APLS and DAWN are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APLS’s TA Score shows that 5 TA indicator(s) are bullish while DAWN’s TA Score has 5 bullish TA indicator(s).

  • APLS’s TA Score: 5 bullish, 6 bearish.
  • DAWN’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, DAWN is a better buy in the short-term than APLS.

Price Growth

APLS (@Biotechnology) experienced а -8.19% price change this week, while DAWN (@Biotechnology) price change was -4.79% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.44%. For the same industry, the average monthly price growth was +17.42%, and the average quarterly price growth was +81.94%.

Reported Earning Dates

APLS is expected to report earnings on Nov 10, 2025.

DAWN is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+0.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APLS($2.92B) has a higher market cap than DAWN($723M). APLS YTD gains are higher at: -27.468 vs. DAWN (-44.317). DAWN has higher annual earnings (EBITDA): -108.37M vs. APLS (-178.43M). DAWN has more cash in the bank: 453M vs. APLS (370M). DAWN has less debt than APLS: DAWN (3M) vs APLS (470M). APLS has higher revenues than DAWN: APLS (755M) vs DAWN (188M).
APLSDAWNAPLS / DAWN
Capitalization2.92B723M404%
EBITDA-178.43M-108.37M165%
Gain YTD-27.468-44.31762%
P/E RatioN/AN/A-
Revenue755M188M402%
Total Cash370M453M82%
Total Debt470M3M15,651%
FUNDAMENTALS RATINGS
APLS: Fundamental Ratings
APLS
OUTLOOK RATING
1..100
7
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
48
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APLSDAWN
RSI
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
78%
Bullish Trend 3 days ago
77%
Momentum
ODDS (%)
Bullish Trend 3 days ago
77%
Bullish Trend 3 days ago
83%
MACD
ODDS (%)
Bullish Trend 3 days ago
77%
Bearish Trend 3 days ago
81%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
85%
Bearish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 10 days ago
81%
Bullish Trend 9 days ago
80%
Declines
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
81%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
84%
Bearish Trend 3 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
APLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
DAWN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINFX39.97N/A
N/A
MFS International Intrinsic Value R2
FSAVX62.05N/A
N/A
Fidelity Select Automotive Port
ASMZX14.91N/A
N/A
Alger Weatherbie Specialized Growth Z
JSGRX30.94N/A
N/A
JHancock U.S. Growth R2
WBIIX15.73-0.12
-0.76%
William Blair Instl International Gr

APLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, APLS has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if APLS jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APLS
1D Price
Change %
APLS100%
-4.12%
DNLI - APLS
49%
Loosely correlated
+1.34%
ARWR - APLS
43%
Loosely correlated
-0.80%
DYN - APLS
43%
Loosely correlated
+10.26%
VTYX - APLS
41%
Loosely correlated
-1.48%
DAWN - APLS
41%
Loosely correlated
-1.88%
More

DAWN and

Correlation & Price change

A.I.dvisor indicates that over the last year, DAWN has been loosely correlated with DNLI. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if DAWN jumps, then DNLI could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DAWN
1D Price
Change %
DAWN100%
-1.88%
DNLI - DAWN
49%
Loosely correlated
+1.34%
RVMD - DAWN
49%
Loosely correlated
-2.56%
IDYA - DAWN
48%
Loosely correlated
+1.12%
OCUL - DAWN
48%
Loosely correlated
-5.40%
IMTX - DAWN
46%
Loosely correlated
+0.85%
More